Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Molecular Biology

• Publication date

  2003-09-26

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0022-2836(03)00927-6PMID 12972252
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.

  2003cited by this paper
• Channel formation by serum amyloid A: a potential mechanism for amyloid pathogenesis and host defense

  2002cited by this paper
• Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease?

  2002cited by this paper
• Neurodegenerative disease: Amyloid pores from pathogenic mutations

  2002cited by this paper
• Faculty Opinions recommendation of Neurodegenerative disease: amyloid pores from pathogenic mutations.

  2002cited by this paper
• Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism.

  2002cited by this paper
• Huntingtin Spheroids and Protofibrils as Precursors in Polyglutamine Fibrilization*

  2002cited by this paper
• The channel hypothesis of Alzheimer's disease: current status.

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases

  2002cited by this paper
• Genetics of Parkinson's disease and biochemical studies of implicated gene products.

  2002cited by this paper
• Charge states rather than propensity for beta-structure determine enhanced fibrillogenesis in wild-type Alzheimer's beta-amyloid peptide compared to E22Q Dutch mutant.

  2002cited by this paper
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

  2002cited by this paper
• Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.

  2002influential reference
• Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes.

  2002cited by this paper
• Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes.

  2002cited by this paper
• Charge states rather than propensity for β‐structure determine enhanced fibrillogenesis in wild‐type Alzheimer's β‐amyloid peptide compared to E22Q Dutch mutant

  2002cited by this paper
• Genetics of Parkinson's disease and biochemical studies of implicated gene products.

  2002cited by this paper
• Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells.

  2002cited by this paper
• Prion channel proteins and their role in vacuolation and neurodegenerative diseases

  2002cited by this paper
• Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.

  2001cited by this paper
• New developments in animal models of Alzheimer’s disease

  2001cited by this paper
• Protofibrils, the unifying toxic molecule of neurodegenerative disorders?

  2001cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation

  2001influential reference
• Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils.

  2001cited by this paper
• In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.

  2001cited by this paper
• Pore formation by beta-2-microglobulin: A mechanism for the pathogenesis of dialysis associated amyloidosis

  2001cited by this paper
• Channel activity of deamidated isoforms of prion protein fragment 106–126 in planar lipid bilayers

  2001cited by this paper
• Pathogenic effects of D23N Iowa mutant amyloid beta -protein.

  2001cited by this paper
• Membrane insertion of the heptameric staphylococcal alpha-toxin pore. A domino-like structural transition that is allosterically modulated by the target cell membrane.

  2001cited by this paper
• Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.

  2001cited by this paper
• Scanning transmission electron microscopy of DNA-protein complexes.

  2001cited by this paper
• Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease.

  2001cited by this paper
• Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein*

  2001cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

  2001cited by this paper
• Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.

  2000cited by this paper
• Genetics of Alzheimer's disease--routes to the pathophysiology.

  2000cited by this paper
• Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.

  2000cited by this paper
• PAN, the proteasome-activating nucleotidase from archaebacteria, is a protein-unfolding molecular chaperone

  2000cited by this paper
• E. coli hemolysin E (HlyE, ClyA, SheA): X-ray crystal structure of the toxin and observation of membrane pores by electron microscopy.

  2000cited by this paper
• Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐Protein

  2000cited by this paper
• Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson’s disease?

  2000cited by this paper
• Polyglutamine‐induced ion channels: a possible mechanism for the neurotoxicity of huntington and other CAG repeat diseases

  2000cited by this paper
• Structural studies of soluble oligomers of the alzheimer β-amyloid peptide

  2000cited by this paper
• Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein.

  2000cited by this paper
• Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.

  2000cited by this paper
• Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease.

  1999cited by this paper
• Alzheimer amyloid aβ1–42 channels: Effects of solvent, pH, and congo red

  1999cited by this paper
• The Molecular Chaperone aB-crystallin Enhances Amyloid Neurotoxicity

  1999cited by this paper
• The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions.

  1999cited by this paper
• Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain*

  1999cited by this paper
• Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

  1999cited by this paper
• Interaction between Aβ (1-42) and Aβ (1-40) in Alzheimer's β-amyloid fibril formation in vitro

  1999cited by this paper
• Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro.

  1999cited by this paper
• Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

  1999cited by this paper
• Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.

  1999cited by this paper
• Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons

  1999cited by this paper
• Assembly of Aβ Amyloid Protofibrils: An in Vitro Model for a Possible Early Event in Alzheimer's Disease†

  1999cited by this paper
• The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity.

  1999cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• What do we learn from a few familial Alzheimer's disease cases?

  1998cited by this paper
• Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.

  1998cited by this paper
• Observation of metastable Aβ amyloid protofibrils by atomic force microscopy

  1997cited by this paper
• Alzheimer's disease: genotypes, phenotypes, and treatments.

  1997cited by this paper
• Mutations in the transmembrane domain of APP altering gamma-secretase specificity.

  1997cited by this paper
• The Alzheimer family of diseases: many etiologies, one pathogenesis?

  1997cited by this paper
• Observation of metastable Abeta amyloid protofibrils by atomic force microscopy.

  1997cited by this paper
• Alzheimer's Disease--Genotypes, Phenotype, and Treatments

  1997influential reference
• Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

  1997cited by this paper
• The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry.

  1996cited by this paper
• SPIDER and WEB: processing and visualization of images in 3D electron microscopy and related fields.

  1996cited by this paper
• Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (*)

  1996cited by this paper
• Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.

  1996cited by this paper
• alpha-1-antichymotrypsin interaction with A beta (1-40) inhibits fibril formation but does not affect the peptide toxicity.

  1996cited by this paper
• α-1-Antichymotrypsin interaction with Aβ (1–40) inhibits fibril formation but does not affect the peptide toxicity

  1996cited by this paper
• Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths.

  1994cited by this paper
• Biology of Disease Human Amyloidosis, Alzheimer Disease and Related Disorders

  1989cited by this paper
• Human amyloidosis, Alzheimer disease and related disorders.

  1988cited by this paper

• Amyloid β 1-42 Can Form Ion Channels as Small as Gramicidin in Model Lipid Membranes

  2025cites this paper
• E22G Aβ40 fibril structure and kinetics illuminate how Aβ40 rather than Aβ42 triggers familial Alzheimer’s

  2024cites this paper
• Key Factors Controlling Fibril Formation of Proteins

  2024cites this paper
• Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons

  2024cites this paper
• Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

  2024cites this paper
• Early events during the aggregation of Aβ16-22-derived switch-peptides tracked using Protein Charge Transfer Spectra.

  2024cites this paper
• Diversity of Aβ aggregates produced in a gut-based Drosophila model of Alzheimer’s disease

  2024cites this paper
• Imaging Amyloid‐β Membrane Interactions: Ion‐Channel Pores and Lipid‐Bilayer Permeability in Alzheimer's Disease

  2023cites this paper
• Imaging Amyloid‐β Membrane Interactions: Ion‐Channel Pores and Lipid‐Bilayer Permeability in Alzheimer's Disease

  2023cites this paper
• Aβ-oligomers: A potential therapeutic target for Alzheimer's disease.

  2023cites this paper
• Beyond Amyloid Fibers: Accumulation, Biological Relevance, and Regulation of Higher-Order Prion Architectures

  2022cites this paper
• Current understandings and perspectives of petroleum hydrocarbons in Alzheimer’s disease and Parkinson’s disease: a global concern

  2022cites this paper
• The role of amyloids in Alzheimer's and Parkinson's diseases.

  2021cites this paper
• Calcium Ions Aggravate Alzheimer’s Disease Through the Aberrant Activation of Neuronal Networks, Leading to Synaptic and Cognitive Deficits

  2021cites this paper
• Neurodegeneration & Imperfect Ageing: Technological Limitations and Challenges?

  2021cites this paper
• Elevating the Levels of Calcium Ions Exacerbate Alzheimer’s Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau

  2021cites this paper
• Distinct types of amyloid‐β oligomers displaying diverse neurotoxicity mechanisms in Alzheimer's disease

  2021cites this paper
• The Pathogenesis Mechanism, Structure Properties, Potential Drugs and Therapeutic Nano-particles Against the Small Oligomers of Amyloid-β.

  2020cites this paper
• Nanoscale Interplay of Membrane Composition and Amyloid Self-Assembly.

  2020cites this paper
• Half a century of amyloids: past, present and future.

  2020cites this paper
• The C291R Tau Variant Forms Different Types of Protofibrils

  2020cites this paper
• Mechanisms of Regulation of Amyloid-Induced Permeability of Model Lipid Membranes by Polyphenols

  2019cites this paper
• New Mechanism of Amyloid Fibril Formation.

  2019cites this paper
• Identification of prion protein-derived peptides of potential use in Alzheimer's disease therapy.

  2018cites this paper
• An impedimetric micro-immunosensing assay to detect Alzheimer's disease biomarker: Aβ40.

  2018cites this paper
• Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology

  2018cites this paper
• [Molecular mechanism of amyloid formation by Ab peptide: review of own works].

  2018cites this paper
• Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer’s disease

  2018influential citation
• To Be Fibrils or To Be Nanofilms? Oligomers Are Building Blocks for Fibril and Nanofilm Formation of Fragments of Aβ Peptide.

  2018cites this paper
• Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments

  2018cites this paper
• Seed-induced acceleration of amyloid-β mediated neurotoxicity in vivo

  2017cites this paper
• Rosetta Stone for Amyloid Fibrils: The Key Role of Ring-Like Oligomers in Amyloidogenesis

  2017cites this paper
• A biocatalytic and thermoreversible hydrogel from a histidine-containing tripeptide.

  2017cites this paper
• Amyloid beta: structure, biology and structure-based therapeutic development

  2017cites this paper
• Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.

  2016cites this paper
• Mitochondrial dysfunction in a transgenic mouse model expressing human amyloid precursor protein (APP) with the Arctic mutation

  2016cites this paper
• Kinetics of Amyloid Formation by Different Proteins and Peptides: Polymorphism and Sizes of Folding Nuclei of Fibrils

  2016cites this paper
• Title Amyloid-Protein Dimers Rapidly Form Stable SynaptotoxicProtofibrils

  2016cites this paper
• Characterization of Inter- and Intramolecular Interactions of Amyloid Fibrils by AFM-Based Single-Molecule Force Spectroscopy

  2016cites this paper
• Amyloid-β and amyloid associated proteins in the pathology and diagnosis of Alzheimer's disease

  2016cites this paper
• Assessment of structural properties of amyloid aggregates and their application potential

  2016cites this paper
• One of the possible mechanisms of amyloid fibrils formation based on the sizes of primary and secondary folding nuclei of Aβ40 and Aβ42.

  2016cites this paper
• The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer’s Disease Amyloid-β Peptide

  2016cites this paper
• Increased Epileptiform EEG Activity and Decreased Seizure Threshold in Arctic APP Transgenic Mouse Model of Alzheimer's Disease.

  2016cites this paper
• [Physico-chemical methods for studing β-amyloid aggregation].

  2015cites this paper
• Comparisons with Amyloid-β Reveal an Aspartate Residue That Stabilizes Fibrils of the Aortic Amyloid Peptide Medin

  2015cites this paper
• Aqueous, Unfolded OmpA Forms Amyloid-Like Fibrils upon Self-Association

  2015cites this paper
• Structural Evidence of Amyloid Fibril Formation in the Putative Aggregation Domain of TDP-43.

  2015cites this paper
• Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23.

  2015cites this paper
• Structural and computational studies of amyloids and noxious folds in biomolecules

  2015cites this paper
• Aβ42-oligomer Interacting Peptide (AIP) neutralizes toxic amyloid-β42 species and protects synaptic structure and function

  2015cites this paper
• The thermodynamics of protein aggregation reactions may underpin the enhanced metabolic efficiency associated with heterosis, some balancing selection, and the evolution of ploidy levels.

  2015cites this paper
• Crucial role of nonspecific interactions in amyloid nucleation

  2014cites this paper
• Investigating the aggregation of β-amyloid peptide (Aβ₄₂) and its interactions with lipid bilayers using advanced microscopy techniques

  2014cites this paper
• Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.

  2014cites this paper
• Animal Models of Alzheimer’s Disease

  2014cites this paper
• Simulations suggest possible novel membrane pore structure.

  2014cites this paper
• Screening for Novel Inhibitors of Alpha-Ynuclein Seeded Nucleation-Dependent Aggregation and Toxicity as a Potential Therapeutic Strategy for Parkinson’s Disease

  2014cites this paper
• Structure–Function Studies of Amyloid Pores in Alzheimer’s Disease as a Case Example of Neurodegenerative Diseases

  2014cites this paper
• Methods for Studying and Structure–Function Relationships of Non-Fibrillar Protein Assemblies in Alzheimer's Disease and Related Disorders

  2014cites this paper
• The Continuum of Metabolic Stress According to the Gas Model ofAlzheimerâÂÂs Disease

  2014cites this paper
• Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis

  2014cites this paper
• The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-β Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice

  2014cites this paper
• Arctic mutant Aβ40 aggregates on α7 nicotinic acetylcholine receptors and inhibits their functions

  2014cites this paper
• Amyloid fibrils are nanoparticles that target lysosomes.

  2014cites this paper
• Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients

  2014cites this paper
• Peptide self-assembly: from toxins to amyloid fibrils and nanotubes.

  2014cites this paper
• Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics

  2014cites this paper
• Complexation of amyloid fibrils with charged conjugated polymers.

  2014cites this paper
• Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)

  2014cites this paper
• Structural Diversity of Alzheimer's Disease Amyloid-β Dimers and Their Role in Oligomerization and Fibril Formation

  2014cites this paper
• Assembly of Amyloid β-Protein Variants Containing Familial Alzheimer's Disease- Linked Amino Acid Substitutions

  2014cites this paper
• Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs.

  2014cites this paper
• Specific domains of Aβ facilitate aggregation on and association with lipid bilayers.

  2013cites this paper
• The Off-rate of Monomers Dissociating from Amyloid-β Protofibrils*

  2013cites this paper
• A Structure-Toxicity Study of Aß42 Reveals a New Anti-Parallel Aggregation Pathway

  2013cites this paper
• The role of the prion protein in neurodegenerative disorders

  2013cites this paper
• Assessing the causes and consequences of co-polymerization in amyloid formation

  2013cites this paper
• Single Molecule Characterization of the Interactions between Amyloid-β Peptides and the Membranes of Hippocampal Cells

  2013cites this paper
• Biophysical characterization and cross-seeding properties of LFAOs, novel prion-like oligomers of the Amyloid-beta peptide involved in Alzheimer’s disease

  2013cites this paper
• In vitro study of α-synuclein protofibrils by cryo-EM suggests a Cu(2+)-dependent aggregation pathway.

  2013cites this paper
• Amyloid-The Off-rate of Monomers Dissociating Protein Structure and Folding :

  2013cites this paper
• Amyloid β-protein oligomers and Alzheimer’s disease

  2013cites this paper
• Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity

  2013cites this paper
• Amyloid Peptide Self-Assembly in Protic Ionic Liquids

  2013cites this paper
• Alzheimer's disease: a gas model. The NADPH oxidase-Nitric Oxide system as an antibubble biomachinery.

  2013cites this paper
• Self-assembling nanomaterials: monitoring the formation of amyloid fibrils, with a focus on small-angle X-ray scattering.

  2013cites this paper
• The Arctic AβPP mutation leads to Alzheimer’s disease pathology with highly variable topographic deposition of differentially truncated Aβ

  2013cites this paper
• Expression and characterisation of cardiovascular amyloid proteins

  2013influential citation
• Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles.

  2013cites this paper
• Misfolding and Amyloid Aggregation of Apomyoglobin

  2013cites this paper
• Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity.

  2012cites this paper
• Multidisniplinary study of Alzheimer's disease-related peptides : from amyloid precursor protein (APP) to amyloid β-oligomers and γ-secretase modulators

  2012influential citation
• Amyloid neuropathology in the single Arctic APP transgenic model affects interconnected brain regions.

  2012cites this paper
• A Study into the Influence of Amyloid-beta Peptide Oxidation on the Rate of Fibril Formation, with a Synthesis of 2-oxo-histidine.

  2012cites this paper
• Alzheimer Aβ peptide interactions with lipid membranes

  2012cites this paper
• Distinct Annular Oligomers Captured along the Assembly and Disassembly Pathways of Transthyretin Amyloid Protofibrils

  2012cites this paper
• The Alzheimer Aβ Peptide : Identification of Properties Distinctive for Toxic Prefibrillar Species

  2012cites this paper
• Methods for Analysis of Amyloid-β Aggregates

  2012cites this paper
• Structural polymorphism and possible pathways of amyloid fibril formation on the example of insulin protein

  2012cites this paper